Incannex Healthcare reported net income of -$4.35M for the quarter ended Mar 2026. This income statement covers 16 quarters of results from Jun 2021 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2021 | Jun2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 1.17M | 0.65M | 1.15M | 11.59M | 11.97M | 13.68M | ||||||||||
| Revenue & cost | ||||||||||||||||
| Revenue | 0.07M | 0.01M | ||||||||||||||
| Operating items | ||||||||||||||||
| Research & DevelopmentR&D | 1.55M | 1.64M | 1.71M | 2.61M | 2.64M | 3.28M | 4.36M | 2.90M | 1.41M | 2.73M | 3.70M | 1.12M | 2.28M | 0.32M | ||
| Selling, General & AdministrativeSG&A | 2.09M | 2.01M | 2.48M | 2.28M | 5.34M | 4.14M | 5.40M | 3.43M | 3.60M | 2.27M | 3.83M | 5.67M | 4.71M | 3.73M | ||
| Other Operating ExpensesOther Opex | -1.09M | |||||||||||||||
| Operating ExpensesOpex | 3.64M | 3.65M | 4.19M | 4.89M | 7.98M | 7.42M | 9.76M | 6.33M | 5.02M | 5.00M | 7.53M | 6.79M | 7.00M | 4.05M | ||
| Operating IncomeOp. Inc | -3.64M | -3.65M | -4.19M | -4.89M | -7.98M | -7.42M | -9.74M | -6.25M | -5.00M | -5.00M | -7.53M | -6.79M | -7.00M | -4.05M | ||
| EBIT | -3.64M | -3.65M | -4.19M | -4.89M | -7.98M | -7.42M | -9.74M | -6.25M | -5.00M | -5.00M | -7.53M | -6.79M | -7.00M | -4.05M | ||
| Non-operating items | ||||||||||||||||
| Non Operating Interest Expenses | -0.03M | -0.03M | 0.13M | -0.01M | -0.01M | |||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.06M | 0.16M | 0.09M | 0.07M | 0.02M | 0.07M | 0.04M | 0.03M | 0.03M | 0.00M | 0.00M | 0.01M | ||||
| Other Non Operating IncomeOther Non Op Inc. | -0.00M | -0.01M | -0.01M | -0.01M | -0.01M | -0.33M | -0.99M | -0.48M | -0.01M | -0.02M | 0.03M | |||||
| Non Operating IncomeNon Op. Inc. | 0.72M | 0.08M | 0.02M | 4.17M | 2.74M | 1.38M | 3.31M | 0.83M | -0.89M | 1.03M | -24.07M | 0.39M | 0.47M | 0.17M | ||
| Net income details | ||||||||||||||||
| EBT | -2.92M | -3.57M | -4.17M | -0.73M | -5.24M | -6.03M | -6.43M | -5.42M | -5.89M | -3.97M | -31.60M | -6.41M | -6.52M | -3.88M | ||
| Profit After TaxPAT | -2.92M | -3.77M | -7.75M | -1.24M | -5.24M | -6.85M | -6.13M | -5.42M | -5.89M | -4.06M | -31.44M | -6.41M | -6.52M | -4.35M | ||
| Equity Income | 0.01M | 0.01M | -0.04M | |||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -2.92M | -3.57M | -4.17M | -0.73M | -5.24M | -6.03M | -6.43M | -5.42M | -5.89M | -3.97M | -31.60M | -6.41M | -6.52M | -3.88M | ||
| Consolidated Net IncomeConsol Net Inc. | -2.92M | -3.57M | -4.17M | -0.73M | -5.24M | -6.03M | -6.43M | -5.42M | -5.89M | -3.97M | -31.60M | -6.41M | -6.52M | -3.88M | ||
| Income towards Parent CompanyParent Net Inc | -2.92M | -3.57M | -4.17M | -0.73M | -5.24M | -6.03M | -6.43M | -5.42M | -5.89M | -3.97M | -31.60M | -6.41M | -6.52M | -3.88M | ||
| Net Income towards Common StockholdersNet Income | -2.92M | -3.57M | -4.17M | -0.73M | -5.24M | -6.03M | -6.43M | -5.42M | -5.89M | -3.97M | -31.60M | -6.41M | -6.52M | -3.88M | ||
| Additional items | ||||||||||||||||
| EPS (Basic) | -2.50 | -3.05 | -3.57 | -0.62 | -4.48 | -5.16 | -5.50 | -4.63 | -5.04 | -6.06 | -27.52 | -0.62 | -0.56 | -0.31 | ||
| EPS (Diluted) | -6.06 | -27.52 | -0.62 | -0.56 | -0.31 | |||||||||||
| Shares Outstanding | 1.17M | 1.17M | 1.17M | 1.17M | 1.17M | 1.17M | 1.17M | 1.17M | 1.17M | 1.17M | 1.17M | 0.65M | 1.15M | 10.34M | 11.65M | 12.35M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.65M | 1.15M | 10.34M | 11.65M | 12.35M | |||||||||||
| EBITDA | -3.64M | -3.65M | -4.19M | -4.89M | -7.98M | -7.42M | -9.74M | -6.25M | -5.00M | -5.00M | -7.53M | -6.79M | -7.00M | -4.05M | ||
| Interest ExpensesInt Expense | -0.03M | -0.03M | 0.13M | -0.01M | -0.01M |